Adaptimmune Therapeutics PLC Annual Earnings Per Share, Basic in USD/shares from 2019 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Adaptimmune Therapeutics PLC quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to 2023.
  • Adaptimmune Therapeutics PLC Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.01 USD/shares, a 66.7% increase year-over-year.
  • Adaptimmune Therapeutics PLC Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -0.03 USD/shares, a 62.5% increase year-over-year.
  • Adaptimmune Therapeutics PLC annual Earnings Per Share, Basic for 2023 was -0.09 USD/shares, a 47.1% increase from 2022.
  • Adaptimmune Therapeutics PLC annual Earnings Per Share, Basic for 2022 was -0.17 USD/shares, unchanged from 2021.
  • Adaptimmune Therapeutics PLC annual Earnings Per Share, Basic for 2021 was -0.17 USD/shares, a 13.3% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 +$0.08 +47.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-06
2022 $0 $0 0% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $0 $0 -13.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-06
2020 $0 +$0.07 +31.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-06
2019 $0 Jan 1, 2019 Dec 31, 2019 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.